Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaixiong Qiwei is a Traditional Chinese Medicine (TCM) herbal prescription developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is specifically formulated for the treatment of tension-type headache (TTH). The name indicates a composition of seven herbal ingredients, likely featuring *Bupleurum* (Chai Hu) and *Ligusticum chuanxiong* (Chuan Xiong) as primary components. In the framework of TCM, the formula is designed to soothe the liver, regulate qi, and activate blood circulation to alleviate pain. Clinical evaluation, including randomized controlled trials, has focused on its efficacy in reducing headache frequency and intensity while maintaining a favorable safety profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chaixiong qiwei.